Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 4/2020

01.04.2020 | Cardiac Magnetic Resonance (E Nagel and V Puntmann, Section Editors)

Cardiac Magnetic Resonance in Chagas Disease—an Update

verfasst von: Marina Pascual Izco, Rocío Hinojar, José Luis Zamorano Gómez, Covadonga Fernández-Golfín Lobán

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of this paper is to review the current role of cardiac magnetic resonance (CMR) in Chagas disease.

Recent Findings

CMR is crucial to detect the cardiac involvement in patients with Chagas disease given its ability to assess ventricular function and allow non-invasive tissue characterization.

Summary

Chagas disease is an emerging health problem in non-endemic areas because of growing population movements. Among other imaging modalities, CMR aids in the early detection of cardiac involvement in Chagas disease, allows stage patients in the course of the cardiomyopathy, stratify patients’ prognosis, and subsequently guides management. In addition to its superior ability to assess global and regional biventricular function, CMR allows the detection and quantification of edema and myocardial fibrosis. In addition to conventional tissue characterization sequences, novel quantitative mapping techniques have emerged and are robust parameters in other inflammatory conditions. Despite its promising role to detect and graduate the inflammatory stage of the disease, no specific data in Chagas heart disease is available yet.
Literatur
1.
Zurück zum Zitat Moreira HT, Volpe GJ, Marin-Neto JA, Ambale-Venkatesh B, Nwabuo CC, Trad HS, et al. Evaluation of right ventricular systolic function in Chagas disease using cardiac magnetic resonance imaging. Circ Cardiovasc Imaging. 2017;10(3). Moreira HT, Volpe GJ, Marin-Neto JA, Ambale-Venkatesh B, Nwabuo CC, Trad HS, et al. Evaluation of right ventricular systolic function in Chagas disease using cardiac magnetic resonance imaging. Circ Cardiovasc Imaging. 2017;10(3).
2.
Zurück zum Zitat Volpe GJ, Moreira HT, Trad HS, Wu KC, Braggion-Santos MF, Santos MK, et al. Left ventricular scar and prognosis in chronic Chagas cardiomyopathy. J Am Coll Cardiol. 2018;72(21):2567–76.CrossRef Volpe GJ, Moreira HT, Trad HS, Wu KC, Braggion-Santos MF, Santos MK, et al. Left ventricular scar and prognosis in chronic Chagas cardiomyopathy. J Am Coll Cardiol. 2018;72(21):2567–76.CrossRef
3.
Zurück zum Zitat Torreão JA, Ianni BM, Mady C, Naia E, Rassi CH, Nomura C, et al. Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2015;17:97. Torreão JA, Ianni BM, Mady C, Naia E, Rassi CH, Nomura C, et al. Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2015;17:97.
4.
Zurück zum Zitat Puntmann VO, D’Cruz D, Smith Z, Pastor A, Choong P, Voigt T, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6(2):295–301.CrossRef Puntmann VO, D’Cruz D, Smith Z, Pastor A, Choong P, Voigt T, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6(2):295–301.CrossRef
5.
Zurück zum Zitat Winau L, Hinojar Baydes R, Braner A, Drott U, Burkhardt H, Sangle S, et al. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis. 2018;77(11):1590–8. Winau L, Hinojar Baydes R, Braner A, Drott U, Burkhardt H, Sangle S, et al. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis. 2018;77(11):1590–8.
7.
Zurück zum Zitat Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C, et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018;19(4):459–460n.CrossRef Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C, et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018;19(4):459–460n.CrossRef
8.
Zurück zum Zitat Uellendahl M, de Siqueira M, Calado EB, Kalil-Filho R, Sobral D, Ribeiro C, et al. Cardiac magnetic resonance-verified myocardial fibrosis in Chagas disease: clinical correlates and risk stratification. Arq Bras Cardiol. 2016;107(5):460–6.PubMedPubMedCentral Uellendahl M, de Siqueira M, Calado EB, Kalil-Filho R, Sobral D, Ribeiro C, et al. Cardiac magnetic resonance-verified myocardial fibrosis in Chagas disease: clinical correlates and risk stratification. Arq Bras Cardiol. 2016;107(5):460–6.PubMedPubMedCentral
9.
Zurück zum Zitat Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109(10):1250–8. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109(10):1250–8.
10.
Zurück zum Zitat Diaz A, Diaztagle JJ, Olaya A, Mora G, López-Lima I, Ayala C, et al. Cardiovascular magnetic resonance imaging evidence of edema in chronic Chagasic cardiomyopathy. Cardiol Res Pract. 2019;2019:6420364.CrossRef Diaz A, Diaztagle JJ, Olaya A, Mora G, López-Lima I, Ayala C, et al. Cardiovascular magnetic resonance imaging evidence of edema in chronic Chagasic cardiomyopathy. Cardiol Res Pract. 2019;2019:6420364.CrossRef
11.
Zurück zum Zitat Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Ntusi N, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013;6(10):1048–58.CrossRef Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Ntusi N, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013;6(10):1048–58.CrossRef
12.
Zurück zum Zitat Hinojar R, Foote L, Sangle S, Marber M, Mayr M, Carr-White G, et al. Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment. Int J Cardiol. 2016;222:717–26.CrossRef Hinojar R, Foote L, Sangle S, Marber M, Mayr M, Carr-White G, et al. Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment. Int J Cardiol. 2016;222:717–26.CrossRef
13.
Zurück zum Zitat Hinojar R, Foote L, Arroyo Ucar E, Jackson T, Jabbour A, Yu C-Y, et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging. 2015;8(1):37–46.CrossRef Hinojar R, Foote L, Arroyo Ucar E, Jackson T, Jabbour A, Yu C-Y, et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging. 2015;8(1):37–46.CrossRef
14.
Zurück zum Zitat Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E. T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology. 2017;285(1):63–72.CrossRef Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E. T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology. 2017;285(1):63–72.CrossRef
15.
Zurück zum Zitat García-Álvarez A. Myocardial delayed enhancement in Chagas heart disease: ready for the clinical arena? J Am Coll Cardiol. 2018;72(21):2588–90.CrossRef García-Álvarez A. Myocardial delayed enhancement in Chagas heart disease: ready for the clinical arena? J Am Coll Cardiol. 2018;72(21):2588–90.CrossRef
16.
Zurück zum Zitat Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309(9):896–908.CrossRef Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309(9):896–908.CrossRef
17.
Zurück zum Zitat Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging. 2016;9(12):1392–402. Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging. 2016;9(12):1392–402.
18.
Zurück zum Zitat Regueiro A, García-Álvarez A, Sitges M, Ortiz-Pérez JT, De Caralt MT, Pinazo MJ, et al. Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. Int J Cardiol. 2013;165(1):107–12.CrossRef Regueiro A, García-Álvarez A, Sitges M, Ortiz-Pérez JT, De Caralt MT, Pinazo MJ, et al. Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. Int J Cardiol. 2013;165(1):107–12.CrossRef
19.
Zurück zum Zitat Rassi A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006;355(8):799–808.CrossRef Rassi A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006;355(8):799–808.CrossRef
20.
Zurück zum Zitat Senra T, Ianni BM, Costa ACP, Mady C, Martinelli-Filho M, Kalil-Filho R, et al. Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy. J Am Coll Cardiol. 2018;72(21):2577–87.CrossRef Senra T, Ianni BM, Costa ACP, Mady C, Martinelli-Filho M, Kalil-Filho R, et al. Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy. J Am Coll Cardiol. 2018;72(21):2577–87.CrossRef
Metadaten
Titel
Cardiac Magnetic Resonance in Chagas Disease—an Update
verfasst von
Marina Pascual Izco
Rocío Hinojar
José Luis Zamorano Gómez
Covadonga Fernández-Golfín Lobán
Publikationsdatum
01.04.2020
Verlag
Springer US
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 4/2020
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-020-9532-2

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.